Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ELI-216 demonstrates euphoria blocking effect

Feb. 19, 2007

Phase I results for SPI-1005 in noise-induced hearing loss reported at the ARO meeting

Feb. 19, 2007

Promising results for Hylenex in INFUSE-Morphine study

Feb. 19, 2007

Inhibition of endocannabinoid degradation: a novel strategy for the treatment of Parkinson's disease

Feb. 19, 2007

BrainStorm's adult stem cell technology studied in Parkinson's disease in primates

Feb. 16, 2007

Tikvah Therapeutics licenses compounds for anxiety-related disorders

Feb. 16, 2007

5-HT4 activation inhibits Abeta secretion and increases survival of neurons oversecreting Abeta

Feb. 16, 2007

Recent patents describe novel agents for anxiety, depression, psychosis etc.

Feb. 16, 2007

Silenor NDA filing on track for Q3 2007

Feb. 15, 2007

GW and Otsuka establish strategic cannabinoid alliance

Feb. 15, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...